| Literature DB >> 24671571 |
Xin Wang1, Zhi-Fei Wang, Yan-Ming Xie, Wen Zhang, Xing Liao, Yan-Peng Chang.
Abstract
Pharmacoeconomics is an important part of the postmarketing Chinese medicine (CM) evaluation, and postmarketing pharmacoeconomic evaluation can reveal the clinical and market value of CM. The purpose of establishing the guideline for pharmacoeconomic evaluation is to make the evaluation process and results regarding Chinese patent medicines both scientific and fair. Every country's guidelines for pharmacoeconomic evaluation act as reference guidelines, we have already drawn up the guideline that takes into account the special characteristics of CM; and these are in preparation for the postmarketing CM pharmacoeconomic evaluation.Mesh：
Substances：
Year: 2014 PMID： 24671571 DOI： 10.1007/s11655-014-1749-y
Source DB: PubMed Journal: Chin J Integr Med ISSN： 1672-0415 Impact factor: 1.978